Teva to Restart Generic Animal Vaccine Production at Missouri Plant Following $14 Million FDA Compli

Teva to Restart Generic Animal Vaccine Production at Missouri Plant Following $14 Million FDA Compliance Investment, an Industrial Info News Alert

ID: 100862

(firmenpresse) - SUGAR LAND, TX -- (Marketwire) -- 01/04/12 -- Researched by Industrial Info Resources (Sugar Land, Texas) -- In 2009, (NASDAQ:TEVA) (Petah Tikva, Israel), the largest U.S. manufacturer of , was ordered by the U.S. Food and Drug Administration (FDA) to cease operations at its facility in St. Joseph, Missouri. The subsidiary of Israel-based Teva Pharmaceuticals had failed to comply with current Good Manufacturing Practice (cGMP) regulations in its quality control, employee training and manufacturing practices. However, the compliance project is slowly winding down, and the plant should resume operations in the first quarter of this year.

For details, view the entire article by subscribing to Industrial Info's Premium Industry News at , or browse other breaking industrial news stories at .

Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, and eight offices outside of North America, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle™, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. To contact an office in your area, visit the "" page.





Contact:
Joe Govreau
713-783-5147



Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  Infocast's Projects & Money Returns -- Jan 2012 Interference Filters for Photolithography
Bereitgestellt von Benutzer: MARKETWIRE
Datum: 04.01.2012 - 11:40 Uhr
Sprache: Deutsch
News-ID 100862
Anzahl Zeichen: 0

contact information:
Town:

SUGAR LAND, TX



Kategorie:

Consulting



Diese Pressemitteilung wurde bisher 280 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Teva to Restart Generic Animal Vaccine Production at Missouri Plant Following $14 Million FDA Compliance Investment, an Industrial Info News Alert"
steht unter der journalistisch-redaktionellen Verantwortung von

Industrial Info Resources (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Industrial Info Resources



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z